All Posts By

Smartkarma Daily Briefs

Daily Brief Quantitative Analysis: Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies and more

By | Daily Briefs, Quantitative Analysis

In today’s briefing:

  • Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies


Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies

By William Mann

  • Novel Twist Steepening Analysis: Empirically validated sector rotation opportunities in the current yield curve environment with rising long-term rates and falling short-term rates.
  • Integrated Machine Learning Framework: Advanced ML techniques identify non-linear macro-asset relationships traditional models miss, enhancing strategy robustness during regime transitions.
  • Actionable Cross-Asset Implementation: Detailed portfolio methodologies integrating findings across asset classes with specific trade recommendations for Q2 2025.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Technical Analysis: Lockout Rally Continues; Still Short-Term Bullish on SPX and more

By | Daily Briefs, Technical Analysis

In today’s briefing:

  • Lockout Rally Continues; Still Short-Term Bullish on SPX, Now Upgrading I.T. Outlook to Bullish Also


Lockout Rally Continues; Still Short-Term Bullish on SPX, Now Upgrading I.T. Outlook to Bullish Also

By Joe Jasper

  • As discussed for two weeks, we see more and more signs leading us to believe SPX made a major bottom at 4800-4820, which was expected support from our 4/8/25 Compass.
  • We have been short-term bullish since our 4/22/25 Compass — when the SPX was testing 5100-5120 support — but now we are upgrading our intermediate-term outlook to bullish as well.
  • Our short- and intermediate-term outlook will remain bullish as long as the SPX is above 5500

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ESG: Need to Shift from Obsession with Controlling AGM to Sharing the Value of Engagement and more

By | Daily Briefs, ESG

In today’s briefing:

  • Need to Shift from Obsession with Controlling AGM to Sharing the Value of Engagement


Need to Shift from Obsession with Controlling AGM to Sharing the Value of Engagement

By Aki Matsumoto

  • The fact that the FSA did not request filing “more than three weeks in advance” rather than “a few days before the AGM” suggests how much resistance companies are encountering.
  • It is not easy to get a company that is concerned about losing control of an AGM to allow the AGM to be moved to a later date.
  • The tactic of controlling AGM is opposite of interacting with shareholders. Companies that have already converted to management that creates value through engagement aren’t expected to adhere to such tactics.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE and more

By | Daily Briefs, ECM

In today’s briefing:

  • GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE
  • GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements
  • GMO Internet (4784 JP): A Huge US$1.9 Billion Secondary Offering
  • Mirxes Pre-IPO: Challenges for Mass Adoption Become Clearer
  • Hinge Health (HNGE): VC Backed Virtual Therapist Company Seeking $2.6b Valuation
  • SMPP Ltd Pre-IPO – In the Right Space (Defence), at the Right Time but Growth Has Been Inconsistent
  • MNTN, Inc. (MNTN) -Performance Marketing Platform Sets Terms for IPO; Seeking $1.2b Valuation
  • EToro Group Ltd (ETOR): Strong IPO Pricing Outcome Yields Explosive Debut
  • Omada Health (OMDA): Virtual Healthcare Provider for Chronic Conditions Filed for IPO
  • Ravi Infrabuild Projects Ltd Pre-IPO Tearsheet


GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE

By Travis Lundy

  • Last year, GMO injected its internet business into GMO Internet (4784 JP) and took shares as consideration. Somehow, GMO Internet got a TOPIX inclusion earlier this year. 
  • The company has 1.24% float of 3.4mm shares. GMO Internet Group – the parent – will now offload 91.7mm shares in an equity offering to meet TSE Continued Listing Requirements.
  • That is about ¥279bn at current price against float of ¥10bn. Full market cap is ¥850bn. That’s 170x Dec25e Net Income. I expect the price will fall. You were warned. 

GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements

By Nicholas Tan

  • GMO Internet Group (9449 JP) is looking to sell its 33.4% stake in its subsidiary GMO Internet (4784 JP) to meet free-float requirements.
  • As the current free-float is tiny, the deal is more like a quasi-IPO rather than a placement, in our view.
  • In this note, we will talk about the deal dynamics as well as updates on the company’s financial performance.

GMO Internet (4784 JP): A Huge US$1.9 Billion Secondary Offering

By Arun George

  • GMO Internet (4784 JP) has announced a secondary offering of 91.7 million shares, worth around US$1.9 billion.
  • The selling shareholder is GMO Internet Group (9449 JP). The secondary offering aims to increase the tradable share ratio to satisfy the TSE Prime Market’s continued listing criteria.
  • The offering represents 239.4 days of the 1-year ADV, the highest compared to the recent large Japanese placements. Pricing is likely to be on 5 June.

Mirxes Pre-IPO: Challenges for Mass Adoption Become Clearer

By Ke Yan, CFA, FRM

  • After an IPO attempt two years ago, Mirxes filed an updated prospectus in an attempt to raise at least US$100m via a Hong Kong listing.
  • In our previous note, we analyzed its product pipelines and highlighted signs of commercialization challenges.
  • In this note, we note that the company expanded its clinical trial plans. Yet, more data shows that blockbuster-level uptakes are unlikely given the profile of its clinical data.

Hinge Health (HNGE): VC Backed Virtual Therapist Company Seeking $2.6b Valuation

By IPO Boutique

  • The venture-capital backed company set terms for its IPO on Tuesday. The company will be offering 13.666 million shares at a $28-$32 range equating to a valuation of $2.3b-$2.6b.
  • Their revenue was $123.8 million and $82.7 million for the three months ended March 31, 2025 and 2024, respectively, representing a year-over-year growth rate of 50%.
  • This IPO is checking the boxes in terms of growth and the valuation comes at a significant discount to a previous funding round making the deal attractive for new investors. 

SMPP Ltd Pre-IPO – In the Right Space (Defence), at the Right Time but Growth Has Been Inconsistent

By Sumeet Singh

  • SMPP Ltd is planning to raise about US$476m through its upcoming IPO in India.
  • SMPP Ltd. designs and manufactures defence equipment, specialising in ammunition components and personal protection products for the Indian armed forces, police, and security agencies.
  • In this note, we look at the company’s past performance.

MNTN, Inc. (MNTN) -Performance Marketing Platform Sets Terms for IPO; Seeking $1.2b Valuation

By IPO Boutique

  • MNTN set terms for its IPO by offering 11.7mm shares at $14-$16 and will debut on Thursday (5/22). 
  • BlackRock is indicating for up to $30 million in this offering as a cornerstone investor and there is a directed share program locking down another 5% of the deal.
  • Their revenue grew by 47.3% to $64.5 million for the three months ended March 31, 2025, from $43.8 million for the three months ended March 31, 2024.

EToro Group Ltd (ETOR): Strong IPO Pricing Outcome Yields Explosive Debut

By IPO Boutique

  • The company priced 11.9mm shares (upsized from 10.0mm) at $52.00 and opened at $69.69 for a gain of 34.0% at first trade.
  • Our sources stated that the deal finished north of 20-times oversubscribed with the bottom-third of the book being completely shut-out.
  • We believe the company was well-received due to an attractive valuation versus comps and by the performance of the comps in the sessions leading up to this debut.

Omada Health (OMDA): Virtual Healthcare Provider for Chronic Conditions Filed for IPO

By IPO Boutique

  • Omada delivers virtual care between doctor’s visits, providing an engaging, personalized, and integrated experience for their members that is designed to improve their health
  • Revenue increased by 38% from $122.8 million to $169.8 million for the years ended December 31, 2023 and 2024, respectively.
  • The company’s last funding round, Series E (February 2022), secured $192 million in a round led by Fidelity Management & Research with a valuation north of $1bn.

Ravi Infrabuild Projects Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Ravi Infrabuild Projects Ltd (1607447D IN)  (RIPL) is looking to raise about US$178m in its upcoming India IPO. The bookrunners for the deal are Axis, Motilal.
  • RIPL is one of the leading infrastructure construction firms in India, experienced in executing structural projects such as flyovers, bridges, railways, highways, and expressways.
  • RIPL had grown 16.6x in terms of its average order size, reaching INR2,577m (as on Dec 2024), as per the company.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Ohayo Japan | S&P Turns Positive for the Year and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Ohayo Japan | S&P Turns Positive for the Year
  • Japan Morning Connection: A Flurry of Middle East Dealmaking Drives Tech and Aerospace
  • Thematic Report: Will the US MFN Policy for Pharma Impact Indian Pharmaceuticals?
  • Biopharma Week in Review – New CBER Head and MFN Headlines Renew Prior Fears
  • Furniture/Furnishings Weekly: Trendspotting at IKEA; Time for Some (Tariff Policy) Game Theory
  • Sustainable Investing Surveyor Focus on Neste Corporation


Ohayo Japan | S&P Turns Positive for the Year

By Mark Chadwick

  • US stocks ended mixed Wednesday as tech strength lifted the Nasdaq 0.7% for a sixth straight gain
  • Qatar Airways agreed to buy up to 210 Boeing jets worth $96 billion during Trump’s visit, marking a major win for the U.S. plane maker.
  • Sony Group forecasts operating profit of 1.28 trillion yen, up 0.3%, for the fiscal year ending March 2026, including a 100 billion yen tariff impact. 

Japan Morning Connection: A Flurry of Middle East Dealmaking Drives Tech and Aerospace

By Andrew Jackson

  • SMCI signs a major $20bn deal with Saudi Arabia’s DataVolt sending server related names higher and should be positive for cooling module supplier Nidec.  
  • NVDA backed CoreWeave surging as much +10% after hours after numbers and comments from management show a continued demand acceleration for AI infrastructure.
  • Boeing signed its largest deal ever with Qatar airlines for up to 210 widebody planes, with GE Aerospace also locking in an order for 400 engines.  Positive JP Heavies.  

Thematic Report: Will the US MFN Policy for Pharma Impact Indian Pharmaceuticals?

By Sudarshan Bhandari

  • MFN policy aims to align US drug prices with the lowest prices paid by other developed nations, potentially resulting in significant price reductions.
  • Indian pharma players have limited impact, considering only few companies have notable presence in branded markets
  • Repercussions for pharma are wider in terms of potential lower R&D spend along with squeezed margins. Though implementation of policy key moniterable

Biopharma Week in Review – New CBER Head and MFN Headlines Renew Prior Fears

By Water Tower Research

  • Biopharma was heavily pressured by the appointment of Dr. Vinay Prasad as the FDA’s Center for Biologics Evaluation and Research (CBER) head and concerns over Most-Favored-Nation (MFN) drug pricing.
  • The group is again wary of the FDA with Prasad overseeing the regulation of biologics, including vaccines, cell and gene therapies, and blood supply.
  • While not anti-vaccine, Prasad’s ideology is closer to RFK Jr. than former CBER head Peter Marks.

Furniture/Furnishings Weekly: Trendspotting at IKEA; Time for Some (Tariff Policy) Game Theory

By Water Tower Research

  • De-escalatory movement on tariff policy benefited furniture and furnishings stocks.
  • The WTR Commercial/Contract Furniture Index was up 6.5%, the Residential Manufacturers & Suppliers Index was up 2.1%, and the Home Goods Retailers Index was up 2.0%, beating the large- cap indices and the R2K.
  • From modernism to hygge and eco-consciousness at IKEA (1). The core business model remains the same (edited vignettes to showcase design and make it easy to outfit an entire house, ready-to-assemble furniture to cut down on logistics and manufacturing costs), but as FT’s architecture and design critic notes, the aesthetics continue to evolve, tracking important social and generational shifts.

Sustainable Investing Surveyor Focus on Neste Corporation

By Water Tower Research

  • The WTR Sustainable Index was up 1.3% W/W versus the S&P 500 Index (down 0.5%), the Russell 2000 Index (up 0.1%), and the Nasdaq Index (down 0.2%).
  • Energy Technology (12.1% of the index) was up 4.2%, while Industrial Climate and Ag Technology (47.6% of the index) was up 0.5%, ClimateTech Mining was up 1.7%, and Advanced Transportation Solutions (21.5% of the index) was up 1.3%.
  • Top 10 Performers: AZRE, AEVA, GCEH, HLGN, ALLIF, PEV, SHLS, EAF, RUN, EVGO

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: [Japan M&A] – Three+ Years Later and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • [Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)
  • Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme
  • Mayne Pharma (MYX AU): High Risk/Reward as an FDA Letter Causes a Tailspin
  • Insignia Financial (IFL AU): Bain Walks Due To “Macro Uncertainty”. CC Capital’s Still In. For Now
  • Jiangsu Hengrui (1276 HK) H-Share IPO: Index Inclusion Later This Year
  • Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now
  • [Japan M&A/Activism] Infroneer To Buy Out Activist Target Sumi Mits Construction (1821) Cheapish
  • Webjet (WJL AU) In Play: BGH/Weiss’ NBIO And Helloworld’s Substantial Stake
  • Sankyo Co: Big Buyback + Five Years Left Until Opening of Mega MGM Osaka Integrated Casino Resort
  • Fraser Hospitality Trust (FHT SP): Frasers Property’s Light Scheme Offer


[Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)

By Travis Lundy

  • In February 2022, Shimizu Corp (1803 JP) bought an additional 25% to get to 50.1% of Nippon Road (1884 JP). It wasn’t a great price.
  • It was, however, a good trade to buy the dip after, as recommended. I expected Shimizu to come back in one to three years. It took three. 
  • Like last time, the price is light. The multiple is low. There are no synergies in the price analysis, in specific violation of the METI Fair M&A/CorpTakeover Guidelines.  Bah humbug.

Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme

By David Blennerhassett

  • Frasers Hospitality Trust (FHT SP) (FHT) has announced a Scheme Implementation Deed was signed for the S-REIT’s privatisation by its current sponsor, Frasers Property Limited.
  • The Scheme Consideration is S$0.71/unit in cash against the latest adjusted NAV estimate of S$0.63904/unit (vs last NAV of S$0.64160/unit).
  • Back in September 2022, ~3% of units (~4.7% of minorities) voted against Frasers/TCC’s S$0.70/unit Offer. But only 18.8% of minorities actually voted. That deal just failed. 

Mayne Pharma (MYX AU): High Risk/Reward as an FDA Letter Causes a Tailspin

By Arun George

  • Mayne Pharma (MYX AU) shares declined 15.76% after the public disclosure of an untitled FDA letter relating to NEXTSTELLIS promotional materials
  • Mayne opines that the letter is not price sensitive as it does not prevent ongoing NEXTSTELLIS sales. Its response will likely withdraw the problematic presentation and adopt a compliance program. 
  • The scheme is unlikely to be derailed, as I estimate that the MAC clause should not be triggered in the worst-case scenario of no NEXTSTELLIS sales. Risk/reward is attractive. 

Insignia Financial (IFL AU): Bain Walks Due To “Macro Uncertainty”. CC Capital’s Still In. For Now

By David Blennerhassett

  • You could see this coming. With due diligence expected to close on the 15th May, Bain has notified  Insignia Financial (IFL AU) it won’t proceed due to macro uncertainties. 
  • Discussions remain ongoing with CC Capital. No fixed timeline on those talks, although it appears negotiations will extend beyond the 15th May.
  • NBIOs were not an ideal place to hide amid Trump’s trade war. They still aren’t. Insignia is down 14.9% as I type.

Jiangsu Hengrui (1276 HK) H-Share IPO: Index Inclusion Later This Year

By Brian Freitas

  • Jiangsu Hengrui Medicine (600276 CH) could raise up to US$1.6bn in its H-share listing if the Offer Size Adjustment Option and the Overallotment Option are both exercised.
  • There is a big allocation to cornerstone investors that is locked up for 6 months. That eliminates the possibility of Fast Entry inclusion to global indexes.
  • Jiangsu Hengrui (1276 HK) should be added to Southbound Stock Connect from the open of trading on 20 June following the end of the Price Stabilisation period.

Mayne Pharma (MYX AU): Firm Support From Cosette Would Be Welcome About Now

By David Blennerhassett

  • They say bad things come in threes. First, Mayne Pharma (MYX AU)announced TherapeuticsMD (TXMD US)‘s legal lawsuit. Then shares buckled in the wake of Trump’s executive order on pharma.
  • The final straw was the FDA accusing Mayne of giving misleading impression of the risks of its oral birth control pill. Shares are now a whopping 29% adrift of terms.
  • Mayne reckons the lawsuit and the FDA letter are not materially price sensitive; and it intends to move forward with the Scheme. A similar intention from Cosette would be welcome.

[Japan M&A/Activism] Infroneer To Buy Out Activist Target Sumi Mits Construction (1821) Cheapish

By Travis Lundy

  • Noted activist Yoshiaki MURAKAMI and associates owned ~12.5% in March 2024, perhaps a tad more. Now they own ~29%. 
  • Integrated Construction Co INFRONEER Holdings (5076 JP) – congenitally allergic to paying full price for acquisitions – is buying Sumitomo Mitsui Construction (1821 JP) well below FAs’ DCF range midpoints.
  • But MURAKAMI-san has tossed his cards in, agreeing to tender. This looks like it gets done, but there are interesting angles.

Webjet (WJL AU) In Play: BGH/Weiss’ NBIO And Helloworld’s Substantial Stake

By David Blennerhassett


Sankyo Co: Big Buyback + Five Years Left Until Opening of Mega MGM Osaka Integrated Casino Resort

By Douglas Kim

  • On 12 May, Sankyo Co Ltd (6417 JP) announced a big share buyback worth 13.66% of total issued shares (excluding treasury shares).
  • Aggregate amount of the purchase cost is up to 60 billion yen (9.7% of its current market cap).
  • We continue to have a Positive view of Sankyo which continues to demonstrate its commitment to deliver higher shareholder returns through aggressive share buybacks.

Fraser Hospitality Trust (FHT SP): Frasers Property’s Light Scheme Offer

By Arun George

  • Frasers Hospitality Trust (FHT SP) announced a scheme privatisation from Frasers Property Ltd (FPL SP) at S$0.71 cash and permitted distributions (estimated at S$0.0086 per unit).
  • The 2022 scheme failed because it narrowly missed the 75% approval threshold. The current offer is light compared to the 2022 offer in several ways.
  • Emerging retail opposition could make satisfying the headcount test challenging. The offer has not been declared final, and a bump is possible.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Tencent (700 HK): 1Q25 and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Tencent (700 HK): 1Q25, Game Revenue Up by 24% YoY, as Industry Encouraged by Authorities
  • Raymond Lifestyle: Governance Crisis?
  • Sibling Conflict Between Yoon Sang-Hyun (Brother) And Yoon Yeo-Won (Sister) At Kolmar Group
  • Episode 117: Talking Apple in China with Patrick McGee
  • Cognizant Technology Solutions: Focus On Geographical & Industry Diversification For Resilience & Long-Term Value Creation!
  • KLA Corporation: The 6 Most Significant Forces Steering Its Performance into 2025 & Beyond!
  • Part 2: What Could Go Wrong at Chagee (CHA)
  • ANSYS Inc.: Robust Market Growth & Product Portfolio As A Key Growth Enabler!
  • ADP Inc.: Integration & Strategic Partnerships As a Solid Groundwork For Future Growth Opportunities!
  • eBay Is Navigating Tariffs Like a Pro—How Its China Strategy Is Fueling Global Resilience!


Tencent (700 HK): 1Q25, Game Revenue Up by 24% YoY, as Industry Encouraged by Authorities

By Ming Lu

  • In 1Q25, both total revenue and game revenue growth rates accelerated.
  • The authorities have been turning from containing games to encouraging games.
  • We expect the stock has an upside of 34% and a price target of HK$700. Buy.

Raymond Lifestyle: Governance Crisis?

By Nimish Maheshwari

  • Raymond Lifestyle’s stock plummets 60% in six months post-demerger, due to lots of governance lapses.
  • Corporate Governance Crisis: CEO,CFO, Director Resignations, Delayed disclosures, Controversial Remuneration and Many More.
  • The company gave excuses such as inflation, an IT incident, etc. in their management meeting after not being able to deliver the performance.

Sibling Conflict Between Yoon Sang-Hyun (Brother) And Yoon Yeo-Won (Sister) At Kolmar Group

By Douglas Kim

  • There is a brewing sibling conflict at the Kolmar Group. Kolmar Holdings and Kolmar BNH have clashed regarding the reorganization of Kolmar BNH’s board of directors.
  • Yoon Sang-Hyun (brother) wants to shake things up. Yoon Sang-Hyun wants to appoint new members at Kolmar BNH’s BOD but his sister Yoon Yeo-Won is opposing this. 
  • We see a higher upside for Kolmar Holdings. Our base case valuation of Kolmar Holdings is NAV per share of 14,675 won (57.5% upside from current levels).

Episode 117: Talking Apple in China with Patrick McGee

By The Circuit

  • Origin story of the book: Becoming interested in Apple’s Achilles heel in China after being too bullish on the company’s success
  • Focus on the role of manufacturing design engineers in custom manufacturing and orchestration of Apple’s supply chain in China
  • Thesis of the book: Exploring Apple’s strategic positioning in China and the symbiotic relationship between economic scale and customer allure in the luxury market

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Cognizant Technology Solutions: Focus On Geographical & Industry Diversification For Resilience & Long-Term Value Creation!

By Baptista Research

  • Cognizant Technology Solutions reported its financial performance for the first quarter of 2025, demonstrating substantial growth and strategic progress amidst an evolving macroeconomic landscape.
  • Revenue for the quarter was $5.1 billion, reflecting an 8.2% increase year-over-year in constant currency, largely driven by the acquisition of Belcan and organic growth in the Health Sciences and Financial Services sectors.
  • This growth was instrumental in placing Cognizant in what the company refers to as the “Winner’s Circle,” indicating notable progress in achieving strategic targets.

KLA Corporation: The 6 Most Significant Forces Steering Its Performance into 2025 & Beyond!

By Baptista Research

  • KLA Corporation reported strong financial results for the March quarter of 2025, with revenues of $3.06 billion, slightly exceeding the midpoint of their guidance.
  • Their non-GAAP diluted earnings per share (EPS) of $8.41 and GAAP EPS of $8.16 also met the upper end of expectations.
  • This performance was largely driven by robust demand in advanced logic, high-bandwidth memory (HBM), and significant contributions from its advanced packaging businesses.

Part 2: What Could Go Wrong at Chagee (CHA)

By Acid Investments

  • Last week, I wrote a quick article flagging the seemingly absurd valuation discrepancy of Chagee vis-a-vis beverage peers on the HK stock exchange i.e. Mixue and Guming, as well as Luckin Coffee on the OTC markets.
  • Chagee currently trades around ~31 (doing extremely poorly on a good day), and at the bottom of its recent trading range; there is no analyst coverage and the firm has yet to report its Q1 25 results so it’s just really stuck in no-man’s land.
  • I postulated then that delisting risk was an overhang on Chagee, a Chinese ADR, but lo and behold, it appears that the market has shrugged off a large portion of it for the large cap Chinese tech companies.

ANSYS Inc.: Robust Market Growth & Product Portfolio As A Key Growth Enabler!

By Baptista Research

  • ANSYS, Inc., a leader in engineering simulation software, presented mixed financial results for Q3 2023, weighed down by unexpected external challenges yet demonstrating robust business fundamentals.
  • The quarter was significantly impacted by new U.S. Department of Commerce export restrictions on certain products to Chinese entities.
  • These restrictions led to additional vetting requirements, resulting in transaction delays and a $20 million headwind, ultimately causing ANSYS to fall short of its initial revenue and ACV (annual contract value) expectations.

ADP Inc.: Integration & Strategic Partnerships As a Solid Groundwork For Future Growth Opportunities!

By Baptista Research

  • Automatic Data Processing, Inc. (ADP) reported solid financial performance in its third quarter of fiscal year 2025, demonstrating robust capabilities amidst varying global economic conditions.
  • The company achieved a 6% increase in revenue, alongside a 10 basis point rise in adjusted EBIT margin and a 6% growth in adjusted EPS.
  • ADP showed significant growth across its U.S. portfolio, especially in its small business, mid-market, enterprise, and compliance solutions offerings.

eBay Is Navigating Tariffs Like a Pro—How Its China Strategy Is Fueling Global Resilience!

By Baptista Research

  • eBay Inc. began 2025 with results surpassing expectations across key financial metrics, despite a challenging operational environment triggered by ongoing trade policy changes and consumer concerns over increasing prices for imported goods.
  • The first quarter saw a nearly 2% increase in Gross Merchandise Volume (GMV) to approximately $18.8 billion, marking a consecutive streak of positive growth for four quarters.
  • The company’s revenue rose over 1% to $2.58 billion, and non-GAAP earnings per share grew by 10% to $1.38.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics and more

By | Credit, Daily Briefs

In today’s briefing:

  • Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics
  • Lucror Analytics – Morning Views Asia
  • UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics


Biocon Biologics – Earnings Flash – Q4 And FY 2024-25 Results – Lucror Analytics

By Trung Nguyen

  • Biocon Limited’s Q4 and FY 2024-25 results were solid in our view, with robust growth, stable profitability, as well as improved working capital and cash flows.
  • The balance sheet has strengthened, and liquidity is adequate.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Seazen Group, Softbank Group
  • In the US, the April CPI came in below expectations for the third straight month at 2.3% y-o-y (2.4% e / 2.4% p) and 0.2% m-o-m (0.3% e / -0.1% p). Core CPI (excluding food and energy) stood at 2.8% y-o-y (2.8% e / 2.8% p) and 0.2% m-o-m (0.3% e / 0.1% p).

  • Treasuries were largely steady yesterday, as supply pressure from corporate issuances offset the softer than expected April CPI print.


UPL Limited – Earnings Flash – FY 2024-25 Results – Lucror Analytics

By Trung Nguyen

  • UPL Limited’s Q4 and FY 2024-25 results reflected robust revenue growth, substantial margin expansion, a return to profitability and significant debt reduction.
  • This was supported by strong operational execution and strategic initiatives across its global markets.
  • Leverage improved significantly, on account of much lower net debt and higher earnings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: USD Bears Broke The Bandwagon and more

By | Daily Briefs, Macro

In today’s briefing:

  • USD Bears Broke The Bandwagon
  • 100 days later: are all countries emerging markets now?
  • Asia Needs Self-Help
  • CX Daily: Chinese Exporters Move Quickly After Tariff Rollback, but Remain Cautious
  • Asia base oils supply outlook: Week of 12 May
  • Tariffs Add To Uncertainty In Global Tire Markets
  • Americas/EMEA base oils demand outlook: Week of 12 May
  • Global base oils arb outlook: Week of 12 May
  • Global base oils margins outlook: Week of 12 May
  • Americas/EMEA base oils supply outlook: Week of 12 May


USD Bears Broke The Bandwagon

By Phil Rush

  • Investors ask whether threats to the USD’s reserve currency status are resting or dead, whereas we wonder if it was ever alive. Commentators routinely overextend narratives.
  • The USD share of allocated FX reserves is already trending downward. A potential acceleration from smaller deficits and higher tariffs would partly offset the impact.
  • Fuller hedging of USD asset holdings abroad may have already reached its limit. We still see more attractive mispricing elsewhere, such as excessively dovish rate curves.

100 days later: are all countries emerging markets now?

By The Emerging Market Equities Podcast

  • Bob Gilhooly, a senior emerging markets economist at Aberdeen, joins the podcast to discuss Trump’s first 100 days in office and his key outcomes
  • Trump’s focus on trade deficits and tariffs has raised concerns about revenue raising and potential impact on the U.S. deficit
  • Uncertainty surrounding trade negotiations and potential outcomes continues to be a key feature of Trump’s presidency

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


Asia Needs Self-Help

By Priyanka Kishore

  • Despite the ongoing trade talks and tariff de-escalation between the US and China, there is no denying that US trade barriers have risen substantially.
  • The downside risks to growth are high for export-oriented Asia and warrant a stronger policy response from central banks.
  • Their cautious approach risks a sharper slowdown and output falling further behind pre-pandemic trend.

CX Daily: Chinese Exporters Move Quickly After Tariff Rollback, but Remain Cautious

By Caixin Global

  • China-U.S. /: Chinese exporters move quickly after tariff rollback, but remain cautious
  • Whales /In Depth: The precarious fate of China’s only nearshore whales
  • Covid-19 /: New Covid wave in Hong Kong is causing severe infections in children

Asia base oils supply outlook: Week of 12 May

By Iain Pocock

  • Asia’s base oils prices hold firm vs feedstock/gasoil prices, especially for heavy grades.
  • Price-strength suggests supply-tightness continues to outweigh weaker-than-expected demand.
  • That dynamic could ease as weak demand cushions impact of recent/ongoing plant maintenance, speeds up refiners’ stock-replenishment once plants resume operations.

Tariffs Add To Uncertainty In Global Tire Markets

By Farah Miller

  • A new probe from EU on Chinese tire due to start May 19  
  • Lack of clarity on the range of tires under the scope of US auto tariff  
  • Lobbying to suspend or delay the implementation of auto tariff 

Americas/EMEA base oils demand outlook: Week of 12 May

By Iain Pocock

  • US base oils demand likely to stay weaker in face of lower feedstock costs, steady prices and expectations of improvement in supply.
  • Supply remains sufficient to cover demand even with heavy round of plant maintenance work in recent weeks.
  • Lower crude oil prices and signs of slowdown in industrial activity increase incentive to minimize stocks and procure volumes on a need-to basis.

Global base oils arb outlook: Week of 12 May

By Iain Pocock

  • Asia’s Group II base oils prices hold in relatively narrow range relative to US export prices, especially for heavy grades.
  • Steady price levels leave arbitrage from Asia to Americas hard to work, pointing to limited surplus supply.
  • US Group II light-grade export prices hold in narrow range or strengthen relative to CFR India prices since start of Q2 2025.

Global base oils margins outlook: Week of 12 May

By Iain Pocock

  • Global base oils prices mostly extend rise vs feedstock/competing fuel prices.
  • Sustained price-strength for most grades points to tight supply-demand fundamentals.
  • Price-strength incentivizes refiners to maintain or raise output.

Americas/EMEA base oils supply outlook: Week of 12 May

By Iain Pocock

  • US base oils prices hold firm vs feedstock/heating oil prices.
  • Rising margins in Q2 2025 point to tighter supply-demand fundamentals.
  • Cautious demand suggests supply is the key factor driving higher margins.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: BYD, Mayne Pharma, Hainan Meilan International Airport, GMO Internet, Pop Mart International Group L, Dawning Information Industry C, Nippon Road, Ningbo Shuanglin Auto Parts, Frasers Hospitality Trust and more

By | Daily Briefs, Most Read

In today’s briefing:

  • HSTECH Index Rebalance Preview: BYD (1211 HK) Could Replace China Literature (772 HK); Huge Trade
  • Mayne Pharma (MYX AU): MAC Musings
  • Hainan Meilan Intl Airport (357 HK): Hainan SASAC’s Left/Right Pocket MGO
  • GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE
  • Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for June25
  • SSE50 Index Rebalance Preview: 4 Potential Changes in June
  • [Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)
  • CSI 500/1000 Index Rebalance Preview: Strong Near-Term Outperformance
  • GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements
  • Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme


HSTECH Index Rebalance Preview: BYD (1211 HK) Could Replace China Literature (772 HK); Huge Trade

By Brian Freitas

  • The review period for the June rebalance of the HSTECH INDEX ended on 31 March, the changes will be announced on 16 May and implemented on 6 June.
  • Following the launch of the God’s Eye ADAS, BYD (1211 HK) could become eligible for index inclusion after meeting the Autonomous theme and Innovation screening.
  • The inclusion of BYD (1211 HK) in the index could result in China Literature (772 HK) being deleted from the index in June.

Mayne Pharma (MYX AU): MAC Musings

By David Blennerhassett

  • Back on the 21st Feb 2025, Mayne Pharma (MYX AU), a leader in dermatology and women’s health, entered into a Scheme with US-based pharmaceutical outfit, Cosette Pharmaceuticals, at A$7.40/share. 
  • The transaction is progressing – the HSR Act condition was satisfied last week. A Scheme Booklet should be issued shortly, with an expected vote mid-June and late-June/early-July implementation. 
  • Shares declined 3.1% yesterday over concerns a MAC could be triggered on the back of the Trump’s executive order on pharma. The impact is likely mixed, but leans neutral.

Hainan Meilan Intl Airport (357 HK): Hainan SASAC’s Left/Right Pocket MGO

By David Blennerhassett

  • Hainan Meilan International Airport (357 HK) has announced a potential change of control, via the domestic shares. 
  • Haikou Meilan’s major shareholder, Hainan Airport Industrial, has entered into a SPA with Hainan Island (600515 CH) to sell its 50.19% stake, the completion of which triggers an unconditional MGO.
  • The H-share Offer price will be HK$10.62/share. That’s not compelling;  but it’s not meant to be as Hainan Airport Industrial and Hainan Island Construction are ultimately controlled by Hainan SASAC. 

GMO Internet (4784) Offering – This Is a GINORMOUS Re-IPO – AVOID LIKE THE PLAGUE

By Travis Lundy

  • Last year, GMO injected its internet business into GMO Internet (4784 JP) and took shares as consideration. Somehow, GMO Internet got a TOPIX inclusion earlier this year. 
  • The company has 1.24% float of 3.4mm shares. GMO Internet Group – the parent – will now offload 91.7mm shares in an equity offering to meet TSE Continued Listing Requirements.
  • That is about ¥279bn at current price against float of ¥10bn. Full market cap is ¥850bn. That’s 170x Dec25e Net Income. I expect the price will fall. You were warned. 

Hang Seng Index (HSI) Rebalance Preview: Inclusion Candidates for June25

By Brian Freitas

  • Post market close on Friday, Hang Seng Indexes will announce the changes for the Hang Seng Index (HSI INDEX) that will be implemented at the close on 6 June.
  • With no constituent changes, one-way turnover will be 1.9% with 3 stocks being capped and FAF changes for a few stocks due to a methodology change for Secondary Listings. 
  • We highlight 7 stocks that have a higher probability of being added to the index. Everything depends on the index committee, and we would not be surprised by zero changes.

SSE50 Index Rebalance Preview: 4 Potential Changes in June

By Brian Freitas

  • With the review period complete, there are 2 non-constituents in direct inclusion zone and 4 current constituents in direct deletion zone.
  • 4 changes result in a one-way turnover of 5.7%, leading to a round-trip trade of CNY 21.8bn (US$3bn). Index arb balances will increase the impact on the stocks.
  • After drifting in a range, the forecast adds have outperformed the forecast deletes over the last month. There could be further outperformance as we near the announcement date.

[Japan M&A] – Three+ Years Later, Shimizu Comes In To Buy Out Minorities in Nippon Road (1884)

By Travis Lundy

  • In February 2022, Shimizu Corp (1803 JP) bought an additional 25% to get to 50.1% of Nippon Road (1884 JP). It wasn’t a great price.
  • It was, however, a good trade to buy the dip after, as recommended. I expected Shimizu to come back in one to three years. It took three. 
  • Like last time, the price is light. The multiple is low. There are no synergies in the price analysis, in specific violation of the METI Fair M&A/CorpTakeover Guidelines.  Bah humbug.

CSI 500/1000 Index Rebalance Preview: Strong Near-Term Outperformance

By Brian Freitas

  • With the review period complete, there could be 50 changes for the CSI Smallcap 500 Index and 100 changes for the CSI 1000 Index in June.
  • There are a lot of migrations expected between the two indices and the impacts for those stocks are lower with much of the flow cancelling out.
  • The outright adds have outperformed the outright deletes over the last few months with the profit-taking in March giving way to renewed outperformance in April.

GMO Internet Placement: Secondary Sell-Down (Quasi IPO) To Meet Prime Listing Requirements

By Nicholas Tan

  • GMO Internet Group (9449 JP) is looking to sell its 33.4% stake in its subsidiary GMO Internet (4784 JP) to meet free-float requirements.
  • As the current free-float is tiny, the deal is more like a quasi-IPO rather than a placement, in our view.
  • In this note, we will talk about the deal dynamics as well as updates on the company’s financial performance.

Frasers Hospitality Trust (FHT SP): Frasers Property & TCC Reload Scheme

By David Blennerhassett

  • Frasers Hospitality Trust (FHT SP) (FHT) has announced a Scheme Implementation Deed was signed for the S-REIT’s privatisation by its current sponsor, Frasers Property Limited.
  • The Scheme Consideration is S$0.71/unit in cash against the latest adjusted NAV estimate of S$0.63904/unit (vs last NAV of S$0.64160/unit).
  • Back in September 2022, ~3% of units (~4.7% of minorities) voted against Frasers/TCC’s S$0.70/unit Offer. But only 18.8% of minorities actually voted. That deal just failed. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars